CY1116008T1 - Διαδικασια για την παρασκευη των ν-υποκατεστημενων 2-κυανοπυρρολιδινων - Google Patents

Διαδικασια για την παρασκευη των ν-υποκατεστημενων 2-κυανοπυρρολιδινων

Info

Publication number
CY1116008T1
CY1116008T1 CY20151100168T CY151100168T CY1116008T1 CY 1116008 T1 CY1116008 T1 CY 1116008T1 CY 20151100168 T CY20151100168 T CY 20151100168T CY 151100168 T CY151100168 T CY 151100168T CY 1116008 T1 CY1116008 T1 CY 1116008T1
Authority
CY
Cyprus
Prior art keywords
preparation
reaction
resulting compound
substituted
cyanopyrrolidines
Prior art date
Application number
CY20151100168T
Other languages
English (en)
Inventor
Frank Schäfer
Gottfried Sedelmeier
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33301223&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1116008(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0308854A external-priority patent/GB0308854D0/en
Priority claimed from GB0311836A external-priority patent/GB0311836D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CY1116008T1 publication Critical patent/CY1116008T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με μία διαδικασία για την παρασκευή μίας Ν-(Ν΄-υποκατεστημένης γλυκυλο)-2-κυανο-πυρρολιδίνης η οποία περιλαμβάνει τουλάχιστον (α) την αντίδραση, παρουσία διμεθυλοφορμαμιδίου, μίας ένωσης με τον τύπο (V) όπου, ανεξάρτητα το ένα από το άλλο, το Χ1 και το Χ3 είναι αλογόνο, το Χ2 είναι αλογόνο, OH, O-C(=O)-CH2X3, -O-SO2-(C1-8) αλκύλιο ή -O-SO2-(αρύλιο) με το L-προλιναμίδιο, και στη συνέχεια με (β) την αντίδραση της ένωσης που προκύπτει χωρίς καθαρισμό με έναν παράγοντα αφυδρογόνωσης, και στη συνέχεια με (γ) την αντίδραση, παρουσία μίας βάσης, της ένωσης που προκύπτει χωρίς καθαρισμό με μία κατάλληλη αμίνη και (δ) την ανάκτηση της ένωσης που προκύπτει σε ελεύθερη μορφή ή στη μορφή ενός όξινου άλατος προσθήκης.
CY20151100168T 2003-04-16 2015-02-18 Διαδικασια για την παρασκευη των ν-υποκατεστημενων 2-κυανοπυρρολιδινων CY1116008T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0308854A GB0308854D0 (en) 2003-04-16 2003-04-16 Organic compounds
GB0311836A GB0311836D0 (en) 2003-05-22 2003-05-22 Process for the manufacture of organic compounds
EP04727557.3A EP1620396B1 (en) 2003-04-16 2004-04-15 Process for the preparation of n-substituted 2-cyanopyrrolidines

Publications (1)

Publication Number Publication Date
CY1116008T1 true CY1116008T1 (el) 2017-01-25

Family

ID=33301223

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100168T CY1116008T1 (el) 2003-04-16 2015-02-18 Διαδικασια για την παρασκευη των ν-υποκατεστημενων 2-κυανοπυρρολιδινων

Country Status (31)

Country Link
US (1) US7375238B2 (el)
EP (1) EP1620396B1 (el)
JP (1) JP4672647B2 (el)
KR (1) KR101192538B1 (el)
AR (1) AR044019A1 (el)
AU (2) AU2004230245B2 (el)
BR (1) BRPI0409471B8 (el)
CA (1) CA2520128C (el)
CL (1) CL2004000804A1 (el)
CO (1) CO5700735A2 (el)
CY (1) CY1116008T1 (el)
DK (1) DK1620396T3 (el)
EC (1) ECSP056093A (el)
ES (1) ES2531084T3 (el)
HK (1) HK1087695A1 (el)
HR (1) HRP20150163T1 (el)
IL (1) IL170887A (el)
IS (1) IS2979B (el)
MA (1) MA27765A1 (el)
MX (1) MXPA05011073A (el)
MY (1) MY139476A (el)
NO (1) NO333251B1 (el)
NZ (1) NZ542899A (el)
PE (2) PE20081293A1 (el)
PL (1) PL1620396T3 (el)
PT (1) PT1620396E (el)
RU (1) RU2369598C2 (el)
SG (1) SG160212A1 (el)
SI (1) SI1620396T1 (el)
TW (1) TWI359135B (el)
WO (1) WO2004092127A1 (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR044019A1 (es) 2003-04-16 2005-08-24 Novartis Ag Proceso para la preparacion de 2-cianopirrolidinas n-sustituidas
EP2165703A3 (en) 2004-01-20 2012-03-28 Novartis Pharma AG Direct compression formulation and process
GT200600008A (es) 2005-01-18 2006-08-09 Formulacion de compresion directa y proceso
MX2008001609A (es) * 2005-08-04 2008-02-19 Novartis Ag Sales de vildagliptina.
JP5165584B2 (ja) * 2006-11-29 2013-03-21 田辺三菱製薬株式会社 N−(n’−置換グリシル)−2−シアノピロリジン誘導体の製法
WO2008084383A2 (en) * 2007-01-10 2008-07-17 Medichem, S.A. Process for preparing vildagliptin
CZ2008512A3 (cs) 2008-08-26 2010-03-10 Zentiva, A. S Zpusob prípravy vysoce cistého vildagliptinu
EA034049B1 (ru) * 2009-07-31 2019-12-23 КРКА, д.д., НОВО МЕСТО Гранулят, включающий вилдаглиптин, способ его получения и фармацевтическая композиция
HUP0900638A2 (en) * 2009-10-07 2011-05-30 Egyt Gyogyszervegyeszeti Gyar Adducts of inorganic salts basea on vildaelitpin applicable for preparation of pharmaceutical compositions
IT1400714B1 (it) 2010-07-06 2013-06-28 Chemelectiva S R L Processo ed intermedi per la preparazione di un principio attivo.
HU231050B1 (hu) 2010-08-19 2020-02-28 Egis Gyógyszergyár Nyrt. Eljárás gyógyszerhatóanyag előállítására
ITMI20112224A1 (it) * 2011-12-06 2013-06-07 Chemelectiva S R L Nuovo processo ed intermedi per la sintesi di vildagliptin
IN2012MU01383A (el) * 2012-05-04 2014-02-28
CN103922986B (zh) * 2013-01-16 2017-02-15 上海彩迩文生化科技有限公司 维大列汀及其类似物、中间体及其制备方法和应用
WO2015145467A1 (en) * 2014-03-28 2015-10-01 Laurus Labs Private Limited An improved process for preparing vildagliptin
WO2021234430A1 (en) 2020-05-17 2021-11-25 Lotus International Pte. Ltd. Modified release dosage form comprising vildagliptin and process for manufacturing the same
WO2022003405A1 (en) 2020-07-03 2022-01-06 Savoi Guilherme One-pot process to obtain a pyrrolidine-2-carbonitrile intermediate compound and industrial scale telescopic process to prepare (2s)-1-[n-(3-hydroxyadamantan-1-yl)glycyl]-2-pyrrolidinecarbonitrile (vildagliptin) using same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510369A (en) * 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
TW492957B (en) * 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
CO5150173A1 (es) * 1998-12-10 2002-04-29 Novartis Ag Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
US6380398B2 (en) 2000-01-04 2002-04-30 Novo Nordisk A/S Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
EP1254113A1 (en) * 2000-01-24 2002-11-06 Novo Nordisk A/S N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv
TW583185B (en) * 2000-06-13 2004-04-11 Novartis Ag N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same
JP2002265439A (ja) * 2001-03-08 2002-09-18 Mitsubishi Pharma Corp シアノピロリジン誘導体およびその医薬用途
AR044019A1 (es) 2003-04-16 2005-08-24 Novartis Ag Proceso para la preparacion de 2-cianopirrolidinas n-sustituidas

Also Published As

Publication number Publication date
JP4672647B2 (ja) 2011-04-20
AU2004230245A1 (en) 2004-10-28
WO2004092127A1 (en) 2004-10-28
TWI359135B (en) 2012-03-01
NZ542899A (en) 2009-02-28
BRPI0409471B8 (pt) 2021-05-25
IS2979B (is) 2017-09-15
ES2531084T3 (es) 2015-03-10
PE20081293A1 (es) 2008-11-04
TW200510299A (en) 2005-03-16
US20060199854A1 (en) 2006-09-07
PT1620396E (pt) 2015-03-05
MA27765A1 (fr) 2006-02-01
MY139476A (en) 2009-10-30
AU2008202278A1 (en) 2008-11-20
BRPI0409471B1 (pt) 2015-11-03
DK1620396T3 (en) 2015-02-23
EP1620396A1 (en) 2006-02-01
HK1087695A1 (en) 2006-10-20
KR20060003878A (ko) 2006-01-11
AR044019A1 (es) 2005-08-24
JP2006523645A (ja) 2006-10-19
BRPI0409471A (pt) 2006-05-02
MXPA05011073A (es) 2005-12-12
CL2004000804A1 (es) 2005-02-11
AU2004230245B2 (en) 2008-02-21
SI1620396T1 (sl) 2015-03-31
RU2005135331A (ru) 2006-06-27
HRP20150163T1 (en) 2015-03-27
IS8122A (is) 2005-11-10
PL1620396T3 (pl) 2015-05-29
IL170887A (en) 2013-06-27
ECSP056093A (es) 2006-03-01
PE20050021A1 (es) 2005-03-15
NO20055226L (no) 2005-11-07
KR101192538B1 (ko) 2012-10-17
EP1620396B1 (en) 2014-12-03
SG160212A1 (en) 2010-04-29
CO5700735A2 (es) 2006-11-30
CA2520128A1 (en) 2004-10-28
US7375238B2 (en) 2008-05-20
RU2369598C2 (ru) 2009-10-10
CA2520128C (en) 2012-02-07
NO333251B1 (no) 2013-04-22

Similar Documents

Publication Publication Date Title
CY1116008T1 (el) Διαδικασια για την παρασκευη των ν-υποκατεστημενων 2-κυανοπυρρολιδινων
CY1116119T1 (el) Παραγωγα ισοξαζολο-πυριδινης
CY1109343T1 (el) Παραγωγα αζετιδινης, η παρασκευη τους και οι φαρμακευτικες ενωσεις που τα περιεχουν
CY1108894T1 (el) Νεα παραγωγα βενζιμιδαζολης
CY1112550T1 (el) Παραγωγο δικυκλοεστερα
CY1109882T1 (el) Νεα αλατα ατορβαστατινης και φαρμακευτικες συνθεσεις που τα περιεχουν
CY1107851T1 (el) Παραγωγα πυρολλο-πυριδινης και η χρηση τους ως ανταγωνιστων crth2
ATE355275T1 (de) Stickstoff-enthaltende aromatische ringverbindungen zur behandlung von tumorerkrankungen
CY1106679T1 (el) Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα
PE20070751A1 (es) Derivados de isoxazolidina como inhibidores de la interaccion de proteinas bcl
EA200200253A1 (ru) Ингибиторы клеточной адгезии
CY1114865T1 (el) Νεοι αναστολεις seh και η χρηση toyς
CY1112696T1 (el) Παραγωγα 5-υδροξυμεθυλ-οξαζολιδιν-2-ονης
CY1107468T1 (el) Καρβαμιδικες ενωσεις για χρηση στην προληψη ή την αγωγη διαταραχων του αγχους
DE60133817D1 (de) Verfahren zur herstellung von aplidin und neue antitumoralen derivate, verfahren zu deren herstellung und zu deren verwendung
DK6384A (da) Disubstituerede prolinderivater, fremgangsmaade til fremstilling deraf og deres anvendelse
CY1124909T1 (el) Μεθοδος και ενδιαμεσα για την παρασκευη της βιλαστινης
CY1113733T1 (el) Παραγωγα κινολινονης και οι φαρμακευτικες συνθεσεις αυτων
CY1105550T1 (el) Μεμνο-πεπτιδια, μια διαδικασια για την παρασκευη και τη χρηση τους
TR200003065T2 (tr) Nöraminidazların inhibitörleri olarak pirolidinler.
TW200635911A (en) Sulfanyl substituted phenyl methanones
CY1107567T1 (el) Μεθοδος για την παρασκευη του εσωτepικου αλατος της (r)-ή (s) αμινοκαρνιτινης, των αλατων και των παραγωγων της
NO20064352L (no) Fremgangsmate for fremstilling av pyrrolidinoksimer
TNSN05261A1 (en) Process for the preparation of n-substituted 2-cyanopyrrolidines
DE602004031129D1 (de) Verfahren zur herstellung von quetiapin